Passions

Skiing

Travel

Hiking

Equestrian Sports

Sports & Active Lifestyle

 

Experience

Apollo Endosurgery to Be Acquired by Boston Scientific

February 1, 2023

Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Ben Beerle
Partner, San Francisco
Milson Yu
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Sangitha Palaniappa
Associate, Palo Alto
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Sarah Lightdale
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Jason Savich
Partner, San Francisco
Charity Williams
Partner, San Diego
Jeff Goldman
Special Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Victoria Comesañas
Associate, Los Angeles
Jessica Dallas
Associate, Palo Alto
Katherine Denby
Special Counsel, Washington, DC
Zack Gong
Associate, Shanghai
Wyatt Kernell
Associate, Colorado
Kristina Krasnikova
Associate, Palo Alto
Edmond Lay
Partner, San Diego
Amanda Pacheco
Associate, Palo Alto
Greg Reith
Associate, Washington, DC
Erica Russell
Associate, San Francisco
Rubin Waranch
Associate, Colorado
Katie Weeks
Associate, Palo Alto
Freddy Yip
Associate, Hong Kong

AiFi Closes $65 Million Series B Financing

July 8, 2022

Cooley advised AiFi on its $65 million Series B funding round. Partner Gordon Ho led the Cooley team advising AiFi, which is a flexible artificial intelligence platform that enables retailers to affordably deploy and scale autonomous shopping solutions.

Related contacts

Gordon Ho
Partner, Palo Alto
John T. Stellini
Associate, Palo Alto
Jessica Dallas
Associate, Palo Alto

Related Practices & Industries

Forty Seven Agrees to Sell to Gilead for $4.9 Billion

March 2, 2020

Cooley advised publicly traded clinical-stage immuno-oncology company Forty Seven on its agreement to sell to Gilead for $4.9 billion in all cash. Partners Jamie Leigh, Ben Beerle, Eric Jensen and John McKenna led the Cooley team advising Forty Seven on the transaction, which is expected close in Q2.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Eric Jensen
Senior Counsel, Palo Alto
John McKenna
Partner, Palo Alto
Rowook Park
Partner, San Diego
Kealan Santistevan
Associate, Palo Alto
Rajdeep Roger Bains
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Todd Gluth
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Rubin Waranch
Associate, Colorado
Jessica Dallas
Associate, Palo Alto

Related Practices & Industries

1Life Healthcare - $282 Million IPO

February 4, 2020

Cooley advised 1Life Healthcare, Inc. on its $281.8 million initial public offering of 20,125,000 shares of common stock, including full exercise of the underwriters’ option to purchase additional shares. 1Life Healthcare whose securities now trade on the Nasdaq Global Select Market under the symbol “ONEM,” is a membership-based primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live and click. Partners Matthew Hemington and John McKenna led the Cooley team.

Related contacts

Matthew Hemington
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Blake Martell
Of counsel, San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Eileen Marshall
Partner, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Francis Wheeler
Senior Counsel, Colorado
Jessica Dallas
Associate, Palo Alto

Related Practices & Industries

Admissions and credentials

California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.